These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24930191)

  • 1. A comparative study of chemical and immunological method of fecal occult blood test in the diagnosis of occult lower gastrointestinal bleeding.
    Yeasmin F; Ali MA; Rahman MA; Sultana T; Rahman MQ; Ahmed AN
    Bangladesh Med Res Counc Bull; 2013 Aug; 39(2):52-6. PubMed ID: 24930191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of colorectal diseases in immunological fecal occult blood test (I-FOBT) positive patients in a tertiary care hospital in Bangladesh.
    Mollick SH; Roy PK; Bhuiyan MR; Mia AR; Alam MS; Mollick KA; Pervin S; Hassan MQ
    Mymensingh Med J; 2014 Oct; 23(4):764-9. PubMed ID: 25481598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive values of an immunological fecal occult blood test for the diagnosis of colorectal cancer compared using colonoscopy in symptomatic patients in Yaounde (Cameroon).
    Jovanka TU; Wilson NNA; Winnie BN; Paule NM; Paul T; Isabelle DB; Magloire BS
    BMC Gastroenterol; 2024 Jun; 24(1):198. PubMed ID: 38877426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fecal occult blood--does a hemoglobin-specific tests improve the diagnosis of relevant colonic neoplasms?].
    Gysi B; Lang C; Affolter H
    Schweiz Med Wochenschr; 1991 Jun; 121(26):988-90. PubMed ID: 1862316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population.
    Wong BC; Wong WM; Cheung KL; Tong TS; Rozen P; Young GP; Chu KW; Ho J; Law WL; Tung HM; Lai KC; Hu WH; Chan CK; Lam SK
    Aliment Pharmacol Ther; 2003 Nov; 18(9):941-6. PubMed ID: 14616158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fecal occult blood test in colorectal cancer screening.
    Li JN; Yuan SY
    J Dig Dis; 2019 Feb; 20(2):62-64. PubMed ID: 30714325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS.
    Borges LV; Mattar R; Silva JMKD; Silva ALWD; Carrilho FJ; Hashimoto CL
    Arq Gastroenterol; 2018; 55(2):128-132. PubMed ID: 30043860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The findings and impact of nonrehydrated guaiac examination of the rectum (FINGER) study: a comparison of 2 methods of screening for colorectal cancer in asymptomatic average-risk patients.
    Bini EJ; Rajapaksa RC; Weinshel EH
    Arch Intern Med; 1999 Sep; 159(17):2022-6. PubMed ID: 10510987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal occult blood tests in occult gastrointestinal bleeding.
    Bond JH
    Semin Gastrointest Dis; 1999 Apr; 10(2):48-52. PubMed ID: 10361895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of different stool tests for the detection of cancer of the colon].
    Vogel T; Driemel C; Hauser A; Hansmann A; Lange S; Jonas M; Möslein G
    Dtsch Med Wochenschr; 2005 Apr; 130(14):872-7. PubMed ID: 15800820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of occult upper gastrointestinal tract bleeding: performance differences in fecal occult blood tests.
    Harewood GC; McConnell JP; Harrington JJ; Mahoney DW; Ahlquist DA
    Mayo Clin Proc; 2002 Jan; 77(1):23-8. PubMed ID: 11794453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of combining a immunological fecal occult blood test (latex method) with a chemical test (guaiac method)].
    Hamajima E; Asai T; Okumura S; Yamaguchi H; Katou T; Yamamoto Y; Kinoshita O
    Gan No Rinsho; 1990 Jan; 36(1):71-4. PubMed ID: 2299793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological fecal occult blood test vs. serum ferritin for detection of colorectal neoplasia in high risk asymptomatic population.
    Sobrino-Cossío S; Fenocchi E; Hernández-Guerrero A; Alonso-Lárraga JO; De la Mora-Levy JG; Larracilla-Salazar I
    Rev Gastroenterol Mex; 2011; 76(3):191-8. PubMed ID: 22041307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a New-generation Fecal Immunochemical Test (FIT) With Guaiac Fecal Occult Blood Test (gFOBT) in Detecting Colorectal Neoplasia Among Colonoscopy-referral Patients.
    Guimarães DP; Fregnani JH; Reis RM; Taveira LN; Scapulatempo-Neto C; Matsushita M; Silva SRM; Oliveira CZ; Longatto-Filho A; Eklund C; Paloheimo L; Mauad E; Suovaniemi O; Syrjänen K
    Anticancer Res; 2019 Jan; 39(1):261-269. PubMed ID: 30591467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fecal occult blood test for colorectal cancer screening].
    Wielandt AM; Hurtado C; Moreno M; Zárate A; López-Köstner F
    Rev Med Chil; 2021 Apr; 149(4):580-590. PubMed ID: 34479346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for colon cancer: A test for occult blood.
    Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
    Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
    Nakama H; Kamijo N
    Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract.
    Chiang TH; Lee YC; Tu CH; Chiu HM; Wu MS
    CMAJ; 2011 Sep; 183(13):1474-81. PubMed ID: 21810951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study.
    Levi Z; Birkenfeld S; Vilkin A; Bar-Chana M; Lifshitz I; Chared M; Maoz E; Niv Y
    Int J Cancer; 2011 May; 128(10):2415-24. PubMed ID: 20658527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.